The independent source for health policy research, polling, and news.
1,241-1,260 of 113,144 results
Jurors in New Mexico concluded that Meta violated parts of the state's Unfair Practices Act and engaged in “unconscionable” trade practices that compromised children's safety, the AP reported.
A federal judge said last week that Advisory Committee on Immunization Practices panelists do not have the expertise needed to make vaccine recommendations. Dr. Robert Malone cited "uncompensated labor, incredible hate from many quarters" as some of the reasons for why he quit the panel.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health problems.
Starting in October 2024, eating disorder-related hospitalizations among 8- to 25-year-olds dropped to about 350 per month, which is on par with the pre-pandemic period. Also: the impact of exercise on Alzheimer's risk; sleep EEGs to predict dementia; and more.
In an announcement Monday, House Republicans alleged "rampant hospice fraud" in Southern California that is costing taxpayers tens of millions of dollars. Other states making news: Minnesota, Nebraska, Florida, North Carolina, Missouri, and more.
The study was based on electronic health records and included data from nearly 4 million admissions from 2016 through 2023. Also: Axios looks at how the Trump administration's visa policy may be sidelining possibly thousands of foreign-born doctors.
An estimated 1,126,000 people ended pregnancies in 2025, roughly the same number as in 2024, according to a Guttmacher Institute report. More people relied on telemedicine and fewer people were forced to travel to obtain abortions, the report suggests.
The BA.3.2 variant has been detected in wastewater samples from 25 states. The strain is "genetically distinct from the JN.1 lineages that have circulated in the United States since January 2024,” CDC researchers said. The current formulation of the 2025-26 covid vaccine targets the JN.1 subvariants — which means BA.3.2 might have the ability to evade protection from vaccines.
With the exception of prior authorization, the Centers for Medicare & Medicaid Services is shifting to electronic submission standards for attachments and digital signatures. The agency expects to save $781 million annually with the change. Plus, the challenge of finding a new CDC director.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
Some physicians say insurance coverage for doulas should be the norm. UnitedHealthcare was the first major insurer to offer the benefit nationwide, NBC News reported. Studies suggest doulas can reduce the rates of preterm births, cesarean sections, and postpartum depression. Separately, researchers see a link between midwife care and lower childhood vaccination rates.
There are currently no Lyme disease vaccines approved for people; a previous vaccine from 1998 was pulled from the market after reports of adverse events and poor sales, The Washington Post reported. Plus: Leaders of Jehovah’s Witnesses announced Friday that they will allow church members to receive blood transfusions — with one caveat.
The victim was identified as Nicholas “Nic” Crews, 34, a social work case manager who had worked at the Jasper clinic for nearly three years. Crews died at the hospital a day after the March 17 shooting. His widow is 38 weeks pregnant with their third child, Military.com reported.
That's a 2.6% increase in positions offered compared with 2025, according to the National Resident Matching Program, though a slightly lower percentage of the offered positions were filled, compared with last year.
Individuals could still opt into a different insurance arrangement, according to Medicare Director Chris Klomp. Meanwhile, President Trump's surgeon general nominee is still facing pushback.
The discounted drugs from German manufacturer Boehringer Ingelheim are Jentadueto and Jentadueto XR, for Type 2 diabetes, as well as the COPD drug Striverdi Respimat, NBC News reported. Plus, the effects of the Iran war on drug supply chains; a gene-therapy drug shortage; and more.
Today's early morning highlights from the major news organizations.
© 2026 KFF